WALTHAM, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., a pioneer in organ transplant technologies and services, announces the annual release of the latest GUARDIAN-Heart Clinical Registry report, shared earlier today at the 44th ISHLT Annual Meeting and Scientific Sessions – one of the […]

In a study assessing high-risk heart donors at the 43rd ISHLT Annual Meeting & Scientific Sessions, GUARDIAN-Heart Registry data indicates a significant reduction in Primary Graft Dysfunction (PGD), a severe post-transplant complication, potentially allowing for an increase in donor hearts […]

GUARDIAN Registry data presented at ACC 2023 has shown use of the Paragonix SherpaPak® Cardiac Transport System was associated with improved outcomes as compared to the use of traditional cold storage in LVAD patients undergoing Heart Transplantation.1 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies announced the presentation of the First Report of the GUARDIAN Registry1 at the International Society for Heart and Lung Transplantation 2021 Annual Meeting. The GUARDIAN study is the largest multi-center, international registry specifically focused on donor heart preservation. Clinical investigators from the […]

Paragonix SherpaPak™ Cardiac Transport System provides its pioneering technology for transplant surgeons at first West Coast location CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies announced that its Paragonix SherpaPak™ Cardiac Transport System (CTS) for donor heart preservation and transport is now being used by […]

New data on successful transplantations for high-risk profile donor hearts presented at the American Transplant Congress CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. announced the presentation of new clinical data at the American Transplant Congress (ATC) on the successful use of the Paragonix SherpaPak™ […]

Paragonix SherpaPak™ Cardiac Transport System is the only FDA cleared and CE marked device that safeguards hearts between donor and recipient patients CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced AdventHealth (Orlando, Florida) has adopted its Paragonix SherpaPak™ Cardiac Transport System (CTS) […]

Paragonix SherpaPak™ Cardiac Transport System is the only FDA-cleared and CE-marked device that safeguards hearts between donor and recipient patients CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced that the first series of pediatric donor hearts preserved and transported using Paragonix SherpaPak […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced clinical results presented during the Paragonix SherpaPak™ CTS 2019 International Heart Summit held during the International Society for Heart and Lung Transplantation (ISHLT) 2019 Annual Meeting in Orlando, FL. Five U.S. and European Centers […]